Cat No.
CEI-1137
Description
AS-602801 is a novel, orally active JNK-1 inhibitor entering into Phase II trials for prevention of post-surgical abdominal adhesions and endometriosis in patients.
Abbr
AS-602801(JNK-1 )
CAS No.
848344-36-5
Targets
JNK-1
Chemical Name
(Z)-2-(2-(4-(morpholinomethyl)benzyloxy)pyrimidin-4-yl)-2-(benzo[d]thiazol-2(3H)-ylidene)acetonitrile
M.Wt
457.55
Purity
> 95%
Solubility
DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL
Storage
4 centigrade
Stability
2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
